JANUARY 30, 2019 - "We delivered on our strategy to drive future growth"
Opioid abuse is today the most common cause of death from drug overdose. The problem is greatest in the US, where just over 70,200 Americans died of an overdose in 2017, mainly caused by use of opioids. Orexo’s key market is the US market for buprenorphine/naloxone products which is the gold standard for Medical Assisted Treatments.
MARCH 5 2019 Orexos shareholders are summoned to the annual general meeting, Thursday April 11, at 4 pm CET in Orexo’s facilities in Uppsala, Sweden. For more information, incl. proxy, see the link below or About us/Corporate Governance/AGM at the web where all documents are available.